Cholesterol Within Phosphatidylcholine Liposomes Attenuates the Expression of Cytokines
Open Access
- 9 July 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (13) , e70812
Abstract
Lipid nanoparticles (LNPs) have gained increased interest for their use as carriers of therapeutic drugs and vaccines. These particles can encapsulate high concentrations of chemical drugs and nucleic acids within their lumen, providing protection from the activity of lytic agents. The central components of LNPs are phospholipids that, due to their amphiphilic nature, spontaneously assemble into vesicular structures. The major phospholipid used for LNPs is phosphatidylcholine (PC), which is often supplemented with cholesterol and polyethylene glycol. Phospholipids within LNPs have been considered inert components. However, we have shown that liposomes made of palmitoyl oleoyl phosphatidylcholine (POPC) or palmitoyl oleoyl phosphatidylserine (POPS) induce a massive alteration of gene expression within macrophages (Mϕ), particularly genes involved in the inflammatory response. These observations suggest that phospholipids could play an independent biological role in modulating cellular responses. Since cholesterol plays a crucial role in cellular functions and is a regular component of LNPs, we investigated the effect of the sterol on the inflammatory response induced by POPC liposomes. We reported herewith that the presence of free cholesterol within liposomes reduces the inflammatory response induced by phospholipids. This effect was not recapitulated by esterified or water‐soluble cholesterol and was not dependent on the acidification of late endosomes/lysosomes. Finally, the reduction in cytokine expression by the sterol was due to a decrease in the activation of NF‐kB. Thus, the incorporation of cholesterol into LNPs suppresses the inflammatory response induced by the particles.Keywords
This publication has 46 references indexed in Scilit:
- Reciprocal regulation of inflammation and lipid metabolism by liver X receptorsNature Medicine, 2003
- Consequences of cellular cholesterol accumulation: basic concepts and physiological implicationsJournal of Clinical Investigation, 2002
- ABCA1 as a new therapeutic target for treating cardiovascular diseaseDrug News & Perspectives, 2002
- AtherosclerosisCell, 2001
- Effects of Intracellular Free Cholesterol Accumulation on Macrophage ViabilityArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- STRUCTURE, FUNCTION AND REGULATION OF THE VACUOLAR (H+)-ATPaseAnnual Review of Cell and Developmental Biology, 1997
- Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.Journal of Clinical Investigation, 1997
- Plasma Membranes Contain Half the Phospholipid and 90% of the Cholesterol and Sphingomyelin in Cultured Human FibroblastsJournal of Biological Chemistry, 1989
- Liposomes in Immunology: Multilamellar Phosphatidylcholine Liposomes as a Simple, Biodegradable and Harmless Adjuvant Without any Immunogenic Activity of its ownImmunological Communications, 1980
- The Hydrophobic Effect and the Organization of Living MatterScience, 1978